Item Infomation

Full metadata record
DC FieldValueLanguage
dc.contributor.authorCristina Muñoz-San, Martín-
dc.contributor.authorAna, Montero-Calle-
dc.contributor.authorMaría, Garranzo-Asensio-
dc.date.accessioned2023-04-20T03:31:04Z-
dc.date.available2023-04-20T03:31:04Z-
dc.date.issued2023-
dc.identifier.urihttps://link.springer.com/article/10.1007/s00216-022-04397-6-
dc.identifier.urihttps://dlib.phenikaa-uni.edu.vn/handle/PNK/8126-
dc.descriptionCC BYvi
dc.description.abstractThe glycosylation status of proteins is increasingly used as biomarker to improve the reliability in the diagnosis and prognosis of diseases as relevant as cancer. This feeds the need for tools that allow its simple and reliable analysis and are compatible with applicability in the clinic. With this objective in mind, this work reports the first bioelectronic immunoplatforms described to date for the determination of glycosylated haptoglobin (Hp) and the simultaneous determination of total and glycosylated Hp. The bioelectronic immunoplatform is based on the implementation of non-competitive bioassays using two different antibodies or an antibody and a lectin on the surface of commercial magnetic microcarriers. The resulting bioconjugates are labeled with the horseradish peroxidase (HRP) enzyme, and after their magnetic capture on disposable electroplatforms, the amperometric transduction using the H2O2/hydroquinone (HQ) system allows the single or multiple detection. The developed immunoplatform achieves limits of detection (LODs) of 0.07 and 0.46 ng mL−1 for total and glycosylated Hp in buffer solution, respectively.vi
dc.language.isoenvi
dc.publisherSpringervi
dc.subjectHRPvi
dc.subjectLODsvi
dc.titleFirst bioelectronic immunoplatform for quantitative secretomic analysis of total and metastasis-driven glycosylated haptoglobinvi
dc.typeBookvi
Appears in Collections
OER - Khoa học Tự nhiên

Files in This Item: